OSA's Digital Library

Applied Optics

Applied Optics

APPLICATIONS-CENTERED RESEARCH IN OPTICS

  • Vol. 37, Iss. 31 — Nov. 1, 1998
  • pp: 7168–7183

Modeling of Photosensitizer Fluorescence Emission and Photobleaching for Photodynamic Therapy Dosimetry

Thomas J. Farrell, Robert P. Hawkes, Michael S. Patterson, and Brian C. Wilson  »View Author Affiliations


Applied Optics, Vol. 37, Issue 31, pp. 7168-7183 (1998)
http://dx.doi.org/10.1364/AO.37.007168


View Full Text Article

Acrobat PDF (302 KB)





Browse Journals / Lookup Meetings

Browse by Journal and Year


   


Lookup Conference Papers

Close Browse Journals / Lookup Meetings

Article Tools

Share
Citations

Abstract

Photon diffusion theory was used to model photobleaching and tissue necrosis resulting from broad-beam therapeutic light irradiation of tissue containing a photosensitizer. The photosensitizer fluorescence signal at the tissue surface was simulated with both broad-beam and pencil-beam excitation. The relationship between the decreasing fluorescence signal and the increasing depth of tissue photodynamic damage during treatment was examined. By analyzing spatially resolved fluorescence measured at the tissue surface in terms of an equivalent virtual point or planar source of fluorescence within the tissue, predictions of necrosis depth that are insensitive to a range of initial treatment parameters were shown to be possible. Preliminary measurements in tissue-simulating phantoms supported the main theoretical findings. The potential value and feasibility of this technique for photodynamic therapy dosimetry are discussed.

© 1998 Optical Society of America

OCIS Codes
(170.5180) Medical optics and biotechnology : Photodynamic therapy
(170.5280) Medical optics and biotechnology : Photon migration
(170.6280) Medical optics and biotechnology : Spectroscopy, fluorescence and luminescence

Citation
Thomas J. Farrell, Robert P. Hawkes, Michael S. Patterson, and Brian C. Wilson, "Modeling of Photosensitizer Fluorescence Emission and Photobleaching for Photodynamic Therapy Dosimetry," Appl. Opt. 37, 7168-7183 (1998)
http://www.opticsinfobase.org/ao/abstract.cfm?URI=ao-37-31-7168


Sort:  Author  |  Year  |  Journal  |  Reset

References

  1. H. I. Pass, “Photodynamic therapy in oncology: mechanisms and clinical use,” J. Natl. Cancer Inst. 85, 443–456 (1993).
  2. B. C. Wilson, M. S. Patterson, and L. Lilge, “Implicit and explicit dosimetry in photodynamic therapy: a new paradigm,” Lasers Med. Science 12, 182–199 (1997).
  3. R. A. Weersink, J. E. Hayward, K. R. Diamond, and M. S. Patterson, “Non-invasive in vivo measurements of photosensitizer uptake using diffuse reflectance spectroscopy,” Photochem. Photobiol. 66, 326–335 (1997).
  4. W. M. Star, B. C. Wilson, and M. S. Patterson, “Light delivery and optical dosimetry in photodynamic therapy of solid tumors,” in Photodynamic Therapy, B. W. Henderson and T. J. Dougherty, eds. (Marcel Dekker, New York, 1992), pp. 335–368.
  5. T. H. Foster and M. G. Nichols, “Oxygen sensitivity of PDT determined from time-dependent electrode measurements in spheroids,” in Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy IV, T. J. Dougherty, ed., Proc. SPIE 2392, 141–151 (1995).
  6. M. S. Patterson, B. C. Wilson, and R. Graff, “In vivo tests of the concept of photodynamic threshold dose in normal rat liver photosensitized by aluminum chlorosulphonated phthalocyanine,” Photochem. Photobiol. 51, 343–349 (1990).
  7. W. R. Potter, “PDT dosimetry and response,” in Photodynamic Therapy: Mechanisms, T. J. Dougherty, ed. (SPIE, Bellingham, Wash., 1989), pp. 88–99.
  8. L. O. Svaasand, P. Wyss, M. Wyss, . Tadir, B. J. Tromberg, and M. W. Berns, “Dosimetry model for photodynamic therapy with topically administered photosensitizers,” Lasers Surg. Med. 18, 139–149 (1996).
  9. T. H. Foster and L. Gao, “Dosimetry in photodynamic therapy: oxygen and the critical importance of capillary density,” Radiat. Res. 130, 379–383 (1992).
  10. B. W. Pogue and T. Hasan, “A theoretical study of light fractionation and dose rate effects in photodynamic therapy,” Radiat. Res. 147, 551–559 (1997).
  11. T. J. Farrell, M. S. Patterson, and B. C. Wilson, “A diffusion theory model of spatially resolved, steady-state diffuse reflectance for the noninvasive determination of tissue optical properties in vivo,” Med. Phys. 19, 879–888 (1992).
  12. W. R. Potter, T. S. Mang, and T. J. Dougherty, “The theory of photodynamic therapy dosimetry: consequences of photodestruction of sensitizer,” Photochem. Photobiol. 46, 97–101 (1987).
  13. J. Moan, “Effect of bleaching on porphyrin sensitizers during photodynamic therapy,” Cancer Lett. 33, 45–53 (1986).
  14. M. S. Patterson and B. C. Wilson, “A theoretical study of the influence of sensitizer photobleaching on depth of necrosis in photodynamic therapy,” in Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy III, T. J. Dougherty, ed., Proc. SPIE 2133, 208–219 (1994).
  15. S. L. Jacques, R. Joseph, and G. Gofstein, “How photobleaching affects dosimetry and fluorescence monitoring of PDT in turbid media,” in Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy II, T. J. Dougherty, ed., Proc. SPIE 1881, 168–179 (1993).
  16. A. J. L. Jongen and H. J. C. M. Sterenborg, “Mathematical description of photobleaching in vivo describing the influence of tissue optics on measured fluorescence signals,” Phys. Med. Biol. 42, 1701–1716 (1997).
  17. W. Cheong, S. A. Prahl, and A. J. Welch, “A review of optical properties of biological tissues,” IEEE J. Quantum Electron. 26, 2166–2185 (1990).
  18. J. Mathews and R. L. Walker, Mathematical Methods of Physics (Benjamin/Cummings, Menlo Park, Calif., 1970).
  19. S. G. Bown, C. J. Tralau, P. D. Coleridge-Smith, D. Akdemir, and T. J. Wieman, “Photodynamic therapy with porphyrin and phthalocyanine sensitization: quantitative studies in normal rat liver,” Br. J. Cancer 54, 43–52 (1986).
  20. C. J. Tralau, A. J. MacRobert, P. D. Coleridge-Smith, H. Barr, and S. G. Bown, “Photodynamic therapy with phthalocyanine sensitization: quantitative studies in a transplantable rat fibrosarcoma,” Br. J. Cancer 55, 399–395 (1987).
  21. C. F. Gerald and P. O. Wheatley, Applied Numerical Analysis (Addison-Wesley, Don Mills, Ontario, 1970).
  22. P. R. Bevington and D. K. Robinson, Data Reduction and Error Analysis for the Physical Sciences (McGraw-Hill, New York, 1992).
  23. R. P. Hawkes, “Photodynamic therapy dosimetry through measurement of fluorescence decrease due to photobleaching,” M.S. thesis (McMaster University, Hamilton, Ontario, Canada, 1997).
  24. T. J. Farrell, M. S. Patterson, J. E. Hayward, B. C. Wilson, and E. R. Beck, “A CCD and neural network based instrument for the non-invasive determinations of tissue optical properties in vivo,” in Advances in Laser and Light Spectroscopy to Diagnose Cancer and Other Diseases, R. R. Alfano, ed., Proc. SPIE 2135, 117–128 (1994).
  25. B. C. Wilson, “Photodynamic therapy: light delivery and dosage for second-generation photosensitizers,” in Photosensitizing Compounds: Their Chemistry, Biology and Clinical Use, G. Bock and S. Harnett, eds. (Wiley, Chichester, 1989), pp. 60–77.
  26. M. Keijzer, W. M. Star, and P. R. M. Storchi, “Optical diffusion in layered media,” Appl. Opt. 27, 1820–1824 (1988).
  27. R. A. Groenhuis, H. A. Ferwerda, and J. J. Ten Bosch, “Scattering and absorption of turbid materials determined from reflection measurements. 1. Theory,” Appl. Opt. 22, 2456–2462 (1983).

Cited By

Alert me when this paper is cited

OSA is able to provide readers links to articles that cite this paper by participating in CrossRef's Cited-By Linking service. CrossRef includes content from more than 3000 publishers and societies. In addition to listing OSA journal articles that cite this paper, citing articles from other participating publishers will also be listed.


« Previous Article  |  Next Article »

OSA is a member of CrossRef.

CrossCheck Deposited